Skip to main content

Blindness

0
Pipeline Programs
4
Companies
6
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Wicab
WicabWI - Fitchburg
3 programs
BrainPort V200 DeviceN/A
BrainPort Vision DeviceN/A1 trial
BrainPort Vision ProN/A1 trial
Active Trials
NCT01488786Completed75Est. Apr 2013
NCT04725760Unknown125Est. Sep 2022
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
3 programs
MelatoninN/A
MelatoninN/A1 trial
MelatoninN/A1 trial
Active Trials
NCT00688935Terminated9Est. May 2015
NCT00692094Terminated12Est. Dec 2008
Lighthouse Pharmaceuticals
Lighthouse PharmaceuticalsCA - San Francisco
1 program
BrainPort V200 DeviceN/A1 trial
Active Trials
NCT02393118Unknown20Est. Sep 2016
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
MelatoninN/A1 trial
Active Trials
NCT00691444Terminated10Est. Dec 2015

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
WicabBrainPort Vision Pro
Lighthouse PharmaceuticalsBrainPort V200 Device
WicabBrainPort Vision Device
Oregon TherapeuticsMelatonin
Oregon TherapeuticsMelatonin
Human BioSciencesMelatonin

Clinical Trials (6)

Total enrollment: 251 patients across 6 trials

NCT04725760WicabBrainPort Vision Pro

Evaluation of the Efficacy of the BrainPort Vision Pro on the Performance of Daily Activities in the Profoundly Blind French Population

Start: Oct 2020Est. completion: Sep 2022125 patients
N/AUnknown
NCT02393118Lighthouse PharmaceuticalsBrainPort V200 Device

A Study to Evaluate the BrainPort Vision Device in Individuals Blinded by Traumatic Injury

Start: Sep 2014Est. completion: Sep 201620 patients
N/AUnknown
NCT01488786WicabBrainPort Vision Device

A Study to Evaluate the BrainPort® Vision Device in Subjects Who Are Blind

Start: Oct 2011Est. completion: Apr 201375 patients
N/ACompleted
NCT00688935Oregon TherapeuticsMelatonin

Young Blind Child Melatonin Treatment Study

Start: Jan 2005Est. completion: May 20159 patients
N/ATerminated
NCT00692094Oregon TherapeuticsMelatonin

Blind Elderly Melatonin Treatment Study

Start: Aug 2004Est. completion: Dec 200812 patients
N/ATerminated
NCT00691444Human BioSciencesMelatonin

Blind Child Melatonin Treatment Study

Start: Sep 2002Est. completion: Dec 201510 patients
N/ATerminated

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.